Originalsprog | Engelsk |
---|---|
Tidsskrift | British Journal of Haematology |
Vol/bind | 186 |
Udgave nummer | 3 |
Sider (fra-til) | e35-e39 |
ISSN | 0007-1048 |
DOI | |
Status | Udgivet - aug. 2019 |
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study
Torben Plesner*, Hendrik Tobias Arkenau, Francesca Gay, Monique C. Minnema, Mario Boccadoro, Philippe Moreau, Jamie Cavenagh, Aurore Perrot, Jacob P. Laubach, Jakub Krejcik, Tahamtan Ahmadi, Carla de Boer, Diana Chen, Christopher Chiu, Jordan M. Schecter, Paul G. Richardson
*Kontaktforfatter
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
67
Downloads
(Pure)